Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
29 Oct 24
8-K
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
22 Oct 24
8-K
Entry into a Material Definitive Agreement
17 Oct 24
8-K
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
23 Aug 24
8-K
Entry into a Material Definitive Agreement
23 Jul 24
8-K
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
30 May 24
NT 10-Q
Notice of late quarterly filing
14 May 24
8-K
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
24 Apr 24
10-Q
2023 Q3
Quarterly report
15 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Departure of Directors or Certain Officers
8 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Jan 24
8-K
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
29 Nov 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
15 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Entry into a Material Definitive Agreement
12 Oct 23
8-K
Ocean Biomedical Announces Loan Commitment from Largest Stockholder; Up to $10 Million
6 Oct 23
8-K
Entry into a Material Definitive Agreement
2 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
6 Sep 23
424B3
Prospectus supplement
16 Aug 23
424B3
Prospectus supplement
16 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
DEF 14A
Definitive proxy
4 Aug 23
424B3
Prospectus supplement
3 Aug 23
PRE 14A
Preliminary proxy
24 Jul 23
EFFECT
Notice of effectiveness
10 Jul 23
S-1/A
IPO registration (amended)
6 Jul 23
CORRESP
Correspondence with SEC
6 Jul 23
UPLOAD
Letter from SEC
28 Jun 23
424B3
Prospectus supplement
23 Jun 23
S-1
IPO registration
23 Jun 23
EFFECT
Notice of effectiveness
23 Jun 23
CORRESP
Correspondence with SEC
21 Jun 23
S-1/A
IPO registration (amended)
15 Jun 23
CORRESP
Correspondence with SEC
15 Jun 23
D
$27.00 mm in debt / options / securities to be acquired, sold $7.56 mm, 1 investor
14 Jun 23
Latest ownership filings
SC 13G
Ayrton Capital LLC
14 Feb 24
SC 13G/A
Lighthouse Investment Partners, LLC
14 Feb 24
SC 13G/A
ATW SPAC MANAGEMENT LLC
13 Feb 24
SC 13G/A
BOOTHBAY FUND MANAGEMENT, LLC
13 Feb 24
SC 13G/A
First Trust Capital Management L.P.
12 Feb 24
SC 13G/A
Polar Asset Management Partners Inc.
9 Feb 24
SC 13G/A
Saba Capital Management, L.P.
7 Feb 24
SC 13G/A
Weiss Asset Management LP
26 Jan 24
4
CHIRINJEEV KATHURIA
6 Oct 23
4
SURENDRA K AJJARAPU
24 Mar 23
4/A
SURENDRA K AJJARAPU
24 Mar 23
SC 13D/A
Aesther Healthcare Sponsor, LLC
23 Mar 23
4
SURENDRA K AJJARAPU
2 Mar 23
4
MICHAEL L PETERSON
2 Mar 23
SC 13D
Aesther Healthcare Sponsor, LLC
24 Feb 23
SC 13D
Poseidon Bio, LLC
24 Feb 23
4
Martin D Angle
17 Feb 23
4
M Michelle Berrey
17 Feb 23
4
MICHAEL L PETERSON
17 Feb 23
4
Jerome Ringo
17 Feb 23
3
M Michelle Berrey
17 Feb 23
4
William F Owens
17 Feb 23
4
Jonathan Kurtis
17 Feb 23
3
Martin D Angle
17 Feb 23
4
Jack A Elias
17 Feb 23
3
Robert J Sweeney
17 Feb 23
3
Daniel Behr
17 Feb 23
3
Jerome Ringo
17 Feb 23
3
William F Owens
17 Feb 23
3
Inderjote S Kathuria
17 Feb 23
3
Jonathan Kurtis
17 Feb 23
3
Gurinder S Kalra
17 Feb 23
3
Jack A Elias
17 Feb 23
3
Elizabeth Ng
17 Feb 23
SC 13G/A
Vellar Opportunities Fund Master, Ltd.
17 Feb 23
SC 13G
Vellar Opportunities Fund Master, Ltd.
17 Feb 23
4
CHIRINJEEV KATHURIA
16 Feb 23
3
CHIRINJEEV KATHURIA
16 Feb 23
4
SURENDRA K AJJARAPU
16 Feb 23
SC 13G
First Trust Capital Management L.P.
14 Feb 23